Upgrade to SI Premium - Free Trial

SpyGlass Pharma (SGP)

27.71 +1.55 (5.93%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)

Latest Headlines

H.C. Wainwright Reiterates Buy Rating on SpyGlass Pharma (SGP) October 21, 2026 6:49 AM - StreetInsider Form 8-K SpyGlass Pharma, Inc. For: Oct 19 October 19, 2026 4:10 PM - SEC Filing SpyGlass Pharma reports 4-year glaucoma implant trial data October 19, 2026 8:04 AM - StreetInsider SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System October 19, 2026 8:00 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on SpyGlass Pharma (SGP) October 5, 2026 6:44 AM - StreetInsider SpyGlass Pharma (SGP) Reiterated at Buy by Stifel as AVS Acquisition Announced October 2, 2026 8:03 AM - StreetInsider Form 8-K SpyGlass Pharma, Inc. For: Oct 01 October 1, 2026 8:15 AM - SEC Filing SpyGlass Pharma buys AVS from Santen for $13 million October 1, 2026 8:02 AM - StreetInsider SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability October 1, 2026 8:01 AM - Globe NewsWire Raymond James Starts SpyGlass Pharma (SGP) at Outperform August 14, 2026 6:06 AM - StreetInsider SpyGlass Pharma (SGP) Reports Q2 Loss of $0.59 August 7, 2026 4:15 PM - StreetInsider Form 10-Q SpyGlass Pharma, Inc. For: Jun 30 August 6, 2026 4:42 PM - SEC Filing Form 8-K SpyGlass Pharma, Inc. For: Aug 06 August 6, 2026 4:21 PM - SEC Filing SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates August 6, 2026 4:06 PM - Globe NewsWire Full Article List